USDA green-lights Lyme disease vaccine that targets mice hosts

The US Department of Agriculture (USDA) has conditionally licensed an oral vaccine designed to limit the spread of Borrelia burgdorferi, the bacterium that causes Lyme disease. The vaccine is sprayed onto pellets and distributed in natural settings to be consumed by mice. Lyme disease is the nation’s most common vectorborne disease, and the US Centers…

Read More

First Lyme Disease Vaccine Licensed for Mice

MEMPHIS (Precision Vaccinations) The U.S. Department of Agriculture recently issued a Conditional Licensure for a novel oral vaccine against the wildlife spread of Borrelia burgdorferi, the bacterium responsible for Lyme disease. Announced by US Biologic, Inc. on May 9, 2023, this innovative Borrelia Burgdorferi Bacterin vaccine is spray-coated onto pellets that mice consume. As the expression goes, if you give a mouse a vaccine…..…

Read More

US Biologic Announces USDA Conditional Licensure of Oral Lyme Vaccine for Wildlife

MEMPHIS, Tenn. – US Biologic, a leading global entity in the development, commercialization, and distribution of orally delivered vaccines, announces USDA Conditional Licensure of its novel oral vaccine against the wildlife spread of Borrelia burgdorferi, the bacterium responsible for Lyme disease, the number one vector-borne disease in the U.S. The only known vector is the…

Read More

US Biologic Presents Development of a Chewable Flu Vaccine: Offers New Tool to Increase Vaccine Equity, Avoid Needles, and Reduce Pandemics

Dr. Jolieke G. van Oosterwijk, US Biologic Chief Scientific Officer, presented key findings on a chewable flu vaccine that US Biologic is developing in partnership with the Biomedical Advanced Research and Development Authority (BARDA) Division of Research, Innovation, and Ventures (DRIVe) as part of its Beyond the Needle program. The presentation was held at the…

Read More

US Biologic – A Breakthrough: Edible Vaccine in “Gummy” Form

City Current

Host Jeremy C. Park talks with Dr. Jolieke van Oosterwijk, Chief Scientific Officer with US Biologic, who highlights the Memphis-based company developing groundbreaking orally delivered vaccines, changing global disease prevention and allowing safe, effective, and cost-efficient delivery of preventative interventions to wildlife, companion animals, food animals, and humans. During the interview, Jolieke discusses how they…

Read More

US Biologic Presents at World Vaccine Congress

US Biologic’s CSO, Dr. Jolieke G. van Oosterwijk, presented at the World Vaccine Congress in Washington, D.C. Dr. van Oosterwijk discussed “using zoonotic disease surveillance to guide oral vaccine design” and presented the methods US Biologic uses to prevent pandemic-level diseases. In her talk, Dr. van Oosterwijk explained to the audience the unique nature of oral…

Read More

An Invasive New Tick Is Spreading in the U.S.

“For the first time in 50 years, a new tick species has arrived in the United States — one that in its Asian home range carries fearsome diseases. The Asian long-horned tick, Haemaphysalis longicornis, is spreading rapidly along the Eastern Seaboard. It has been found in seven states and in the heavily populated suburbs of…

Read More